Entity Details

Primary name INF2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ27J81
EntryNameINF2_HUMAN
FullNameInverted formin-2
TaxID9606
Evidenceevidence at protein level
Length1249
SequenceStatuscomplete
DateCreated2008-01-15
DateModified2021-06-02

Ontological Relatives

GenesINF2

GO terms

Show/Hide Table
GOName
GO:0003779 actin binding
GO:0030036 actin cytoskeleton organization
GO:0031267 small GTPase binding
GO:0048471 perinuclear region of cytoplasm
GO:0090140 regulation of mitochondrial fission

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm

Domains

Show/Hide Table
DomainNameCategoryType
IPR003124 WH2 domainDomainDomain
IPR010472 Formin, FH3 domainDomainDomain
IPR010473 Formin, GTPase-binding domainDomainDomain
IPR011989 Armadillo-like helicalFamilyHomologous superfamily
IPR014768 Rho GTPase-binding/formin homology 3 (GBD/FH3) domainDomainDomain
IPR015425 Formin, FH2 domainDomainDomain
IPR016024 Armadillo-type foldFamilyHomologous superfamily
IPR027649 Inverted formin-2FamilyFamily
IPR042201 Formin, FH2 domain superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
613237 OMIMFocal segmental glomerulosclerosis 5 (FSGS5)A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation. The disease is caused by variants affecting the gene represented in this entry.
614455 OMIMCharcot-Marie-Tooth disease, dominant, intermediate type, E (CMTDIE)A form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. The dominant intermediate type E is characterized by clinical and pathologic features intermediate between demyelinating and axonal peripheral neuropathies, and motor median nerve conduction velocities ranging from 25 to 45 m/sec. Patients additionally manifest focal segmental glomerulonephritis, proteinuria, progression to end-stage renal disease, and a characteristic histologic pattern on renal biopsy. The disease is caused by variants affecting the gene represented in this entry.